Clorox (NYSE:CLX) Price Target Raised to $140.00

Clorox (NYSE:CLX) had its price objective upped by research analysts at Barclays from $130.00 to $140.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s price objective would indicate a potential downside of 5.59% from the stock’s previous close.

CLX has been the subject of several other research reports. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday. JPMorgan Chase & Co. boosted their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday. Finally, StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, Clorox currently has a consensus rating of “Hold” and an average target price of $158.21.

Clorox Stock Performance

Shares of CLX stock opened at $148.29 on Wednesday. The firm’s 50 day moving average is $162.25 and its 200 day moving average is $158.76. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. Clorox has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a market capitalization of $18.36 billion, a P/E ratio of 51.67, a PEG ratio of 2.92 and a beta of 0.42.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same quarter in the previous year, the company earned $2.16 earnings per share. On average, sell-side analysts anticipate that Clorox will post 6.86 earnings per share for the current year.

Institutional Trading of Clorox

Large investors have recently modified their holdings of the business. Insight Folios Inc lifted its holdings in Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after buying an additional 63 shares during the period. Integral Investment Advisors Inc. lifted its stake in Clorox by 4.1% in the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after acquiring an additional 67 shares during the period. HCR Wealth Advisors boosted its holdings in Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after acquiring an additional 68 shares in the last quarter. Empower Advisory Group LLC increased its position in Clorox by 4.5% during the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after purchasing an additional 78 shares during the period. Finally, Aviance Capital Partners LLC raised its holdings in Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock worth $502,000 after purchasing an additional 80 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.